Search News Archives
Follow us on
Conferences | Events

Media Partners


Dionex Improves USP Monograph Assay Time for Drug Products Used to Treat Tuberculosis

DionexDionex is proud to announce a new method for improving the United States Pharmacopeia (USP) monograph assays for drug products containing either three or four active pharmaceutical ingredients (APIs) used to treat tuberculosis (TB). This new application, AN 257: HPLC Assay Method for Drug Products Containing Anti-Tuberculosis Active Pharmaceutical Ingredients, uses the hydrolytic-stability-enhanced Acclaim® PolarAdvantage II (PA2) column with an UltiMate® 3000 system to assay drug products using either a conventional HPLC approach or a time- and mobile-phase saving UHPLC approach. All APIs can be determined with one method rather than two, and in less time.

The two HPLC assay methods previously described in the USP monograph require two separate injections and use different mobile phases, requiring equilibration between tests. In comparison, this new single-injection method can determine all four anti-tuberculosis APIs commonly used to treat TB (isoniazid, pyrazinamide, rifampicin, and ethambutolare) in 10 minutes. The analysis of two representative drug products yielded acceptable percentage contents, as judged by the limits in the USP monograph. Further savings and waste reduction are possible with the UHPLC method that requires less than 2 minutes per injection.

This application and many other pharmaceutical analysis methods can be found at under the Markets tab by clicking on Pharmaceuticals.

Dionex (NASDAQ:DNEX) is a global leader in the manufacturing and marketing of liquid chromatography and sample preparation systems, consumables, and software for chemical analysis. The company's systems are used worldwide in environmental analysis and by the life sciences, chemical, petrochemical, food and beverage, power generation, and electronics industries. Our expertise in applications and instrumentation helps analytical scientists to evaluate and develop pharmaceuticals, establish environmental regulations, and produce better industrial products.

Acclaim and UltiMate are registered trademarks of Dionex Corporation


Popular this Month


Win a PIPETBOY from the new Integra summer collection!


Great Savings off Selected GC Columns


CytoSMART raises 5.2 million Euros for further product innovation and growth


High Volume Sample Storage in Space Efficient 96-Well Format


Cherwell Publishes Guide on Sterility Testing


Effective Removal of DMSO from Stored Samples


ATL Webcast: A Practical Guide to Selecting the Right LIMS


Genetic study reveals how gut bacteria work to keep us healthy


Lonza Establishes Custom Cell Biology Services to Offer Unique Manufacturing and Testing Capabilities


Thermo Fisher Scientific Opens Food Safety Customer Solution Center in India






Can't find what you are looking for?

Search by company or by product

Company Name:




Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd